[Federal Register Volume 77, Number 138 (Wednesday, July 18, 2012)]
[Notices]
[Page 42314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-17459]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-12-0556]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-7570 or send an email to
[email protected]. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Assisted Reproductive Technology (ART) Program Reporting System
(0920-0556, exp. 9/30/2012)--Revision--National Center for Chronic
Disease and Public Health Promotion (NCDDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The ART program reporting system is used to comply with Section
2(a) of Public Law 102-493 (known as the Fertility Clinic Success Rate
and Certification Act of 1992 (FCSRCA)), 42 U.S.C. 263a-1(a)). FCSRCA
requires each ART program to annually report to the Secretary through
the CDC pregnancy success rates achieved by each ART program, the
identity of each embryo laboratory used by such ART program, and
whether the laboratory is certified or has applied for certification
under the Act. The reporting system allows CDC to publish an annual
success rate report to Congress as specified by the FCSRCA.
CDC requests OMB approval to continue information collection for
three years. This Revision request includes an increase in the total
estimated burden hours due to an increase in the estimated number of
responding clinics and an increase in the estimated number of responses
per respondent. In addition, this Revision request describes
implementation of a brief, one-time optional feedback survey at the end
of the data submission for each reporting year. The feedback survey
will elicit information about ART reporting system usability as well as
respondents' perspectives on the usefulness of the information
collection.
Information is collected electronically through the National ART
Surveillance System (NASS), a web-based interface, or by electronic
submission of NASS-compatible files. The NASS includes information
about all ART cycles initiated by any of the ART programs practicing in
the United States and its territories. The system also collects
information about the pregnancy outcome of each cycle as well as a
number of data items deemed important to explain variability in success
rates across ART programs and individuals.
Respondents are the 484 ART programs in the United States.
Approximately 440 ART programs are expected to report an average of 339
ART cycles each. The burden estimate includes the time for collecting,
validating, and reporting the requested information. Information is
collected on an annual schedule.
There are no costs to the respondents other than their time. The
total estimated annualized burden hours are 96,960.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
ART Programs.......................... NASS.................... 440 339 39/60
Feedback Survey......... 176 1 2/60
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Science Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012-17459 Filed 7-17-12; 8:45 am]
BILLING CODE 4163-18-P